Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Spreading Sunshine Policy Takes On Bloated Drug Receipts

This article was originally published in PharmAsia News

Executive Summary

Manipulation of China’s “fapiao”, or receipt system, is not new but now the State Council is cracking down on the practice, aiming to bring down inflated drug prices. Meanwhile, several provinces are cutting wholesale layers in a wider campaign to squeeze price inflation out of the commercial pharma segment.

You may also be interested in...



2016 Review: Pricing, R&D Issues Dominate China Commercial Arena

2016 was again another busy year on the commercial front in China, with market changes, new regulations, and ongoing pricing pressures all affecting the pharma sector. Meanwhile, the push for licensing deals, innovation, and international expansion continued apace.

DTP Pharmacies March On In China: Pharma Ignores At Its Own Risk

A shift in dispensing from hospitals to external pharmacies has led to predictions that the direct-to-patient sales model will be big in China. But only those with the right partnerships and expertise will reap the benefits, leading pharmacy chain executives told a recent conference.

Challenges, Opportunities For Cardinal In China Policy Change

Major US pharma distributor Cardinal Health is further expanding its regional presence in China, with the country’s rapidly changing operating environment presenting opportunities and challenges.

Topics

UsernamePublicRestriction

Register

MT142578

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel